ABSI — AbSci Share Price
Last Trade - 00:00Momentum
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | |||
| EPS Growth (f) | |||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | |||
| Price to Tang. Book | |||
| Price to Free Cashflow | |||
| Price to Sales | |||
| EV to EBITDA | |||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | |||
| Return on Equity | |||
| Operating Margin | |||
Financial Summary
| Year End null | Unit | null | null | null | null | null | nullE | nullE | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Health trend(F-Score)
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Absci Corporation, formerly AbSci LLC, is a synthetic biology company. The Company with its artificial intelligence (AI)-powered integrated drug creation platform enables the creation of protein-based drugs (biologics) by unifying biologic drug discovery and cell line development processes into one process. It uses synthetic biology technologies and deep learning AI to predict, identify, design, construct, screen, select and scale production of biologic drug candidates, and learn from the data it generates. The Company has drug candidates in approximately nine active programs, eight of the active programs are focused on developing production cell lines for drug candidates. It has one discovery program, focused on lead optimization with Astellas. Its active programs include Bispecific mAb, Bispecific T-cell engager, Cytokine, Fab, Multivalent Fc-fusion, Plasma protein and mAb.
Directors
- Last Annual
- Last Interim
- Incorporated
- January 1st, 1970
- Public Since
- January 1st, 1970
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
- NASDAQ Global Select Market
- Shares in Issue
- NaN
- Address
- 18105 Se Mill Plain Blvd, Suite 350, VANCOUVER, 98683
- Web
- http://www.absci.com/
- Phone
- +1 3609491041
- Auditors
Latest News for ABSI
Similar to ABSI
4D MOLECULAR THERAPEUTICS ORD
NASDAQ Global Select Market
ABCELLERA BIOLOGICS ORD
NASDAQ Global Select Market
ACADIA PHARMACEUTICALS ORD
NASDAQ Global Select Market
ACHILLES THERAPEUTICS ADS
NASDAQ Global Select Market
ACLARIS THERAPEUTICS ORD
NASDAQ Global Select Market
FAQ
As of Today at 19:54 UTC, shares in AbSci are trading at $19.50. This share price information is delayed by 15 minutes.
Shares in AbSci last closed at $19.50 and the price had moved by over the past 365 days. In terms of relative price strength the AbSci share price has matched the S&P500 Index by over the past year.
There is no consensus recommendation for this security.
AbSci does not currently pay a dividend.
AbSci does not currently pay a dividend.
AbSci does not currently pay a dividend.
To buy shares in AbSci you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $19.50, shares in AbSci had a market capitalisation of $0.00m.
Here are the trading details for AbSci:
- Country of listing: United States
- Exchange: NSQ
- Ticker Symbol: ABSI
Based on an overall assessment of its quality, value and momentum AbSci is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like AbSci. Over the past six months, its share price has matched the S&P500 Index by .
As of the last closing price of $19.50, shares in AbSci were trading -22.45% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
We are not able to find PE ratio data for AbSci.
We do not have data on AbSci's directors
We do not have data on AbSci's shareholders